Our research laboratory is dedicating all efforts to basic and translational research on pancreatic cancer and biliary tract cancer, being a leading research team specializing in these fields in the country.
Pancreatic cancer, one of the most lethal cancers for humankind and expected to be the leading cause of cancer-related deaths worldwide by 2030, lacks effective early detection methods and has extremely limited treatment options. Biliary tract cancer is an even more challenging malignancy with a severe shortage of therapeutic options, garnering increasing global attention.
We are conducting truly impactful and clinically relevant research that can genuinely aid patients suffering from pancreatic and biliary tract cancers.
By employing cutting-edge technologies and a multidisciplinary approach, our team aims to elucidate the underlying mechanisms driving these aggressive malignancies and develop novel diagnostic and therapeutic strategies to improve patient outcomes.
We are dedicated to improving the lives of those suffering from these tough diseases. Ultimately, our efforts will help advance cancer research and improve human health.
